70% Of 36 Popular Protein Supplements Sold In India Mislabeled, 14% Contain Toxins, Says New Study

New Delhi: A first-of-its-kind observational analysis of the most popular protein powders sold and consumed in India has shown that the majority of these supplements falter on quality, labelling or advertised claims.

The findings of the analysis carried out on 36 different brands of protein powders, including those containing herbal and dietary supplements such as vitamins, minerals, and other natural or synthetic ingredients, were published in the peer-reviewed journal Medicine last week.

Protein supplements are extracts or concentrates of high protein foodstuff used for bodybuilding and as a dietary supplement to fulfil protein intake in a lean and pure source of proteins and amino acids (the building blocks of proteins).

The analysis showed that nearly 70 percent of the 36 supplements had inaccurate protein information, with some brands offering only half of what they claimed. Also, around 14 percent of samples contained harmful fungal aflatoxins, while 8 percent showed traces of pesticide residue.

Also, noted the authors — clinical researchers associated with Rajagiri Hospital in Kerala and a technology entrepreneur from the US — “most Indian-made herbal protein-based supplements are poor quality and contain liver toxic botanicals”.

“We demonstrate that the protein-based herbal and dietary supplement industry requires stringent scrutiny, regulation, and basic safety studies before being marketed,” the authors said.

Dr Cyriac Abby Philips, hepatologist from Rajagiri Hospital in Aluva in Kerala, the principal investigator of the self-funded study, told ThePrint that though there is published data from various research groups and clinical units across the world on organ damage, especially liver injury due to herbal and dietary supplements, there has been no proactive and prospective analysis of widely utilised supplements — especially protein-based — in published literature.

“There are occasional published reports that look at the quality of whey protein and amino acids analysis in protein supplements to identify amino acid spiking or ‘doping’ to falsely elevate protein content,” he said.

Philips added that one study also looked at how marketed protein supplements adhered to regulations with respect to quality — but much of this was done on protein supplements sold in the US and there were no such studies done from the Asia Pacific region.

“Our work sheds light on regulatory flaccidity, importance of consumers rights in being privy to transparency regarding choosing safe food or supplement options and general apathy of the medical community towards educating the public regarding food and diet supplements that are potentially beneficial versus potentially harmful,” he said.

ThePrint reached G. Kamala Vardhana Rao, chief executive at the Food Safety and Standards Authority of India (FSSAI), over calls, for comments on the findings in the paper but had received no response by the time of publication. This report will be updated if and when a response is received.

In response to a question in the Lok Sabha in August last year, Union Health Minister Mansukh Mandaviya had informed the Lower House that in 2022-23, as many as 38,053 civil cases and 4,817 criminal cases were lodged by the FSSAI for non-conforming food samples including protein powders and dietary supplements.

Related Posts

  • Pharma
  • July 26, 2024
  • 128 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 125 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD